Pazopanib improves progression-free survival without impairing HRQOL

Results of EORTC trial 62072 appearing in Cancer

2015-07-06

(Press-News.org) Results of EORTC trial 62072 appearing in Cancer show that in patients with soft tissue sarcoma, whose disease had progressed during or after prior chemotherapy, pazopanib improved progression-free survival but did not change health-related quality of life. This observed improvement in progression-free survival without impairment of health-related quality of life was considered a meaningful result. There has not been a lot of research that has looked into the quality of life of patients with advanced soft tissue sarcoma. The results of this EORTC health related quality of life study show that the application of pazopanib for soft tissue sarcoma is quite complicated. This study included an array of outcome assessments including not only efficacy and toxicity but also cost effectiveness and patient-reported outcomes, and it has provided much needed data. Dr. Andrew Bottomley, Head of the EORTC Quality of Life Department and co-author of this study says "This is one of the few randomized clinical trials with quality of life studies undertaken in metastatic soft-tissue sarcoma in such a robust manner. It's so important to better understand what treatment options we can offer to these patients, and we hope our results shed more light onto a field that in the past had remained much in the dark." Prof. Winette van der Graaf of Radboud University Medical Center Nijmegen, The Netherlands and coordinator of EORTC trial 62072 points out, "The EORTC health related quality of life study was comprehensive, and although multiple indicators might complicate interpretation of the results, they also provide a more thorough assessment of the impact of pazopanib therapy on the patients and on the impact on the health care system. In the end, this is what is needed to translate clinical trial results to the bedside." Corneel Coens, EORTC Biostatistician and lead author of this study explains, "One of the intentions of this study was to investigate if, by delaying tumor progression, pazopanib would improve the quality of life of these sarcoma patients. An ambitious project as this is a relative rare and mixed patient population with little prior data about quality of life. This study informs us about the treatment balance between improving outcome at the cost of side effects." This study was conducted by the EORTC Soft-Tissue Sarcoma Group and the EORTC Quality of Life Department and supported by a grant from GlaxoSmithKline. Health-related quality of life was assessed using the 30-item core EORTC Quality-of-Life Questionnaire (EORTC QLQ-C30) at baseline and at weeks 4, 8, and 12 in patients who received treatment on protocol.

INFORMATION:

Please also see the accompanying editorial by Dr. Carolyn Gotay of the School of Population and Public Health at the University of British Columbia in Vancouver, Canada.

ELSE PRESS RELEASES FROM THIS DATE:

New study again shows: More strokes with intracranial stents

2015-07-06

The risk of experiencing another stroke is higher if patients, after dilation of their blood vessels in the brain, receive not only clot-inhibiting drugs, but also have stents inserted. The recently published results of the VISSIT study confirm this conclusion of a rapid report by the German Institute for Quality and Efficiency in Health Care (IQWiG) of October 2014. Thus, the available studies still provide no evidence of a benefit of treatment with intracranial stents (also called "percutaneous transluminal angioplasty and stenting", PTAS). This is the conclusion of a ...

Producing biodegradable plastic just got cheaper and greener

2015-07-06

Biodegradable drinking cups or vegetable wrapping foil: the bioplastic known as polylactic acid (PLA) is already a part of our everyday lives. And yet, PLA is not yet considered a full alternative to traditional petroleum-based plastics, as it is costly to produce. Researchers from the KU Leuven Centre for Surface Chemistry and Catalysis now present a way to make the PLA production process more simple and waste-free. Their findings were published in Science. The bioplastic PLA is derived from renewable resources, including the sugar in maize and sugarcane. Fermentation ...

'Rambo' protein may not be so violent after all

2015-07-06

A protein dubbed 'Bcl-Rambo' can protect against heart failure, suggests new research from King's College London and funded by the British Heart Foundation (BHF). The Bcl-Rambo protein (also known as Bcl2-L-13) was named by a Japanese scientist because it was thought to be involved in activating cell death - 'Rambo' also means violence in Japanese. However, it seems that the Rambo movie character's protein counterpart has actually been misjudged. New research shows for the first time that the Bcl-Rambo protein may not be so violent after all and is actually involved in ...

Structural shift elucidated with large-scale atomic simulations

2015-07-06

Iron-nickel alloys are ubiquitous: they are found at the earth's core and in meteorites. What is fascinating about such alloys is that their inner structure can change with rapid temperature swings. Heated up above 730 °C (1,340 °F), these alloys enter what is referred to as an austenitic phase. Alternatively, they can be turned into very hard alloys, referred to as a martensitic phase, by subjecting them to extremely rapid cooling. Now a team of scientists from Germany has, for the first time, created a large-scale simulation involving 275,000 atoms representing ...

Supercharging stem cells to create new therapies

2015-07-06

Researchers at the University of Adelaide have discovered a new method for culturing stem cells which sees the highly therapeutic cells grow faster and stronger. The research, which was published in the prestigious international journal, Stem Cells, is expected to eventually lead to new treatments for transplant patients. Kisha Sivanathan, a PhD student in the University of Adelaide's School of Medicine and the Renal Transplant Unit at the Royal Adelaide Hospital, says this is an exciting breakthrough in stem cell research. "Adult mesenchymal stem cells, which ...

New test could predict arthritis drug failure in patients

2015-07-06

A study of 311 patients by The University of Manchester has found that it may be possible to predict early which rheumatoid arthritis (RA) patients will fail to respond to the biologic drugs given to treat them. These findings could help better manage patients' symptoms. RA is a chronic disease which affects up to 1.5% of the population. It is a significant health burden for patients, who can experience pain, reduced mobility and premature death unless they receive effective treatment. Biologics are a relatively new form of treatment for RA. Given by injection, ...

Fingolimod in RRMS: Indication of added benefit in certain patients

2015-07-06

Pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) reassessed fingolimod (trade name: Gilenya), a drug for the treatment of adults with highly active relapsing remitting multiple sclerosis (RRMS). The Federal Joint Committee (G-BA) had limited its decision on the first assessment from 2012 to three years because it considered the certainty of the data as insufficient. This obliged the drug manufacturer to submit a second dossier. It did not submit any new studies, but reanalysed ...

Significant reduction in serious crimes after juvenile offenders given emotional awareness training

2015-07-06

Scientists believe that a simple two-hour emotional awareness course aimed at making young offenders less aggressive could hold the key to significantly reducing the seriousness of their future crimes. In the first ever study of its kind, psychologists from Cardiff University recorded a 44% drop in the severity of crimes committed by persistent reoffenders, six months following the completion of a course designed to improve their ability to recognise other people's emotions. The findings are published today in PLOS ONE journal. Much has been published previously to ...

Waiting to harvest after a rain enhances food safety

2015-07-06

ITHACA, N.Y. - To protect consumers from foodborne illness, produce farmers should wait 24 hours after a rain or irrigating their fields to harvest crops, according to new research published in the journal Applied and Environmental Microbiology. Rain or irrigation creates soil conditions that are more hospitable to Listeria monocytogenes, which when ingested may cause the human illness Listeriosis. Waiting to harvest crops reduces the risk of exposure to the pathogen, which could land on fresh produce. Cornell scientists, along with other agricultural researchers from ...

Universe's hidden supermassive black holes revealed

2015-07-06

Astronomers have found evidence for a large population of hidden supermassive black holes in the Universe. Using NASA's Nuclear Spectroscopic Telescope Array (NuSTAR) satellite observatory, the team of international scientists detected the high-energy x-rays from five supermassive black holes previously clouded from direct view by dust and gas. The research, led by astronomers at Durham University, UK, supports the theory that potentially millions more supermassive black holes exist in the Universe, but are hidden from view. The findings are being presented at the ...

Pazopanib improves progression-free survival without impairing HRQOL

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: